Robert H. Lurie Cancer Center, Northwestern University — Chicago, Illinois

Robert H. Lurie Cancer Center, Northwestern University is a clinical research site located in Chicago, Illinois, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Robert H. Lurie Cancer Center, Northwestern University has participated in 2 clinical trials.

Therapeutic areas: Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, EGFR Inhibitor-associated Rash.

Sponsors: Biogen, Spectrum Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Robert H. Lurie Cancer Center, Northwestern University?

Robert H. Lurie Cancer Center, Northwestern University has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Robert H. Lurie Cancer Center, Northwestern University conducted?

Robert H. Lurie Cancer Center, Northwestern University has 2 clinical trials on record. Their work covers Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, EGFR Inhibitor-associated Rash.

Is Robert H. Lurie Cancer Center, Northwestern University accredited by Crixeo Health?

Robert H. Lurie Cancer Center, Northwestern University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Robert H. Lurie Cancer Center, Northwestern University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.